Actor portrayal.

About the Study Drug

Lenacapavir is an investigational product and is not approved for HIV prevention by any regulatory authority. Gilead is studying the safety and efficacy of lenacapavir for HIV treatment and prevention in multiple ongoing clinical studies.

To learn more about the ongoing studies of lenacapavir for treatment,
please visit the CAPELLA and CALIBRATE clinical trial sites.